Health-related quality of life and burden of illness in adults with newly diagnosed attention-deficit/hyperactivity disorder in Sweden

Table 4 Patient-reported measures of ADHD symptoms, depression, and HRQoL

Measure	Danderyd (n = 101)		Liljeholmen (n = 88)		Overall (N = 189)
	n	Mean (SD)	n	Mean (SD)	n	Mean (SD)
ASRS-v1.1 score
Screener	1	–	65	5.0 (1.0)	66	5.0 (1.0)
Symptom checklist	98	46.4 (13.0)	11	56.6 (8.7)	109	47.4 (13.0)
MADRS-S score^a	93	20.3 (9.6)	72	19.1 (8.5)	165	19.8 (9.2)
EQ-5D
Index score	95	0.64 (0.27)	67	0.61 (0.30)	162	0.63 (0.28)
VAS	91	58.1 (21.2)	66	56.4 (23.5)	157	57.4 (22.1)

ADHD attention-deficit/hyperactivity disorder, ASRS-v1.1 Adult ADHD Self-Report Scale version 1.1, EQ-5D five-dimension EuroQol questionnaire, HRQoL health-related quality of life, MADRS-S Montgomery–Åsberg Depression Rating Scale – Self-reported, PHQ-9 Patient Health Questionnaire 9, SD standard deviation, VAS visual analog scale
^aMADRS-S scores were converted from PHQ-9 scores for 72 patients from Liljeholmen and one patient from Danderyd using a regression equation (MADRS-S = [1.206 × PHQ-9] + 4.062)

ISSN: 1471-244X